Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Parallel-Group, Double-Blind 4-arm Study to Investigate the Effects of Treatment With LY3549492 Tablets Compared With Placebo in an Obese or Overweight Population With Type-2 Diabetes (T2D)

NCT07030868 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT07030868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07030868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Parallel-Group, Double-Blind 4-arm Study to Investigate the Effects of Treatment With LY3549492 Tablets Compared With Placebo in an Obese or Overweight Population With Type-2 Diabetes (T2D)
Lead sponsor
Eli Lilly and Company
Phase
Phase 2
Overall status
Terminated
Start date
June 19, 2025
Completion date
July 29, 2025
Enrollment
1 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, overweight, type 2 diabetes